Cargando…

Correction to: Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452078/ https://www.ncbi.nlm.nih.gov/pubmed/35993399 http://dx.doi.org/10.1093/labmed/lmac118

Ejemplares similares

Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State
por: Ipe, Tina S, et al.
Publicado: (2022)

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia
por: McKemey, Emily, et al.
Publicado: (2021)

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2022)

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
por: Hocini, Hakim, et al.
Publicado: (2023)

Convalescent Plasma Therapy for COVID-19: State of the Art
por: Focosi, Daniele, et al.
Publicado: (2020)

Correction: SARS-CoV-2-specific immune response in COVID-19 convalescent individuals
por: Pan, Yunbao, et al.
Publicado: (2021)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
por: van Griensven, Johan, et al.
Publicado: (2016)

Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)

Use of convalescent plasma in the treatment of COVID-19
por: Joyner, Michael J., et al.
Publicado: (2023)

Late Treatment for COVID-19 With Convalescent Plasma
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2022)

Correction to: A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol
por: Misset, Benoît, et al.
Publicado: (2021)

Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
por: Casadevall, Arturo, et al.
Publicado: (2021)

Correction to: Trends of Clinical and Health Care Resource Utilization in Heart Failure Admissions in the United States
Publicado: (2020)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
por: Psaltopoulou, Theodora, et al.
Publicado: (2020)

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Treatment for emerging viruses: Convalescent plasma and COVID-19
por: Brown, Bethany L., et al.
Publicado: (2020)

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021)

Early Outpatient Treatment for Covid-19 with Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2022)

Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
por: Murakami, Naoka, et al.
Publicado: (2023)

Correction to: Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Author Correction: Modeling COVID-19 scenarios for the United States
Publicado: (2020)

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
por: Tremblay, Douglas, et al.
Publicado: (2020)

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
por: Salazar, Eric, et al.
Publicado: (2020)

The Association Between Convalescent Plasma Treatment and Survival of Patients with COVID-19
por: Kuno, Toshiki, et al.
Publicado: (2021)

The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
por: Iranijam, Effat, et al.
Publicado: (2022)

Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
por: Peng, Henry T, et al.
Publicado: (2021)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8c85h2elft6i4q7ca56l3n6gqn